Zhitong Finance App News, Jinhe Biotech (002688.SZ) issued an announcement. The company's board of directors reviewed and passed the “Proposal on Foreign Investment and Construction Projects by US Subsidiaries”, agreeing that the US subsidiary Farmaway Pharmaceutical Co., Ltd. will implement a veterinary additive factory (Omaha factory) renovation and expansion project and the US subsidiary Famaway Biotech Co., Ltd. to implement a new veterinary vaccine factory expansion project. The total estimated total investment for the above projects is approximately US$31.924,600.

Among them, the total investment for the veterinary additive plant (Omaha plant) renovation and expansion project is estimated to be about US$5.909 million, and the total investment of the new veterinary vaccine plant expansion project is estimated to be about US$26.15,600 (including leasing costs). The implementation of the above projects is to meet the company's business development needs, enhance the company's comprehensive strength and competitive advantage in overseas markets, and help enhance the company's overall profitability and core competitiveness.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.